Wendy Smith Begolka

1 month ago | dermatologytimes.com | Emma Andrus |Renata Block |Wendy Smith Begolka

"The patient experience and the eczema journey is so important," said Wendy Smith Begolka, MBS, the Chief Strategy Officer at the National Eczema Association (NEA). Renata Block, MMS, PA-C, a board-certified physician assistant in Chicago, Illinois, and a Dermatology Times Editorial Advisory Board member, and Begolka discussed efforts to address disparities in eczema diagnosis and treatment, particularly among diverse patient groups.

1 month ago | dermatologytimes.com | Emma Andrus |Renata Block |Wendy Smith Begolka

"The impact on mental health is a major aspect that patients noted, which often goes unnoticed in clinical definitions," said Wendy Smith Begolka, MBS, the Chief Strategy Officer at the National Eczema Association (NEA).

1 month ago | dermatologytimes.com | Emma Andrus |Renata Block |Wendy Smith Begolka

CommentaryArticleMarch 12, 2025Author(s):,Renata Block, MMS, PA-C, speaks with Wendy Smith Begolka, MBS, of the National Eczema Association about NEA’s strategic efforts in community outreach, health care provider engagement, and patient education.

1 month ago | healio.com | Richard Gawel |Kristen Dowd |John Luo |Wendy Smith Begolka

Key takeaways: Social stigma and pruritus impact the mental health of patients with atopic dermatitis. Reduced risks persisted across subgroups including age, sex, race and atopic comorbidities. Patients with dupilumab prescriptions for their atopic dermatitis had lower risks for psychiatric and sleep disorders than those prescribed other treatments, according to a study published in Annals of Allergy, Asthma & Immunology.